Condition: Parkinson's Disease · Sponsor: Hoffmann-La Roche
The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of prasinezumab compared with placebo in participants with early-stage Parkinson's disease (PD) on stable symptomatic monotherapy with levodopa.
This description comes directly from the study's public registry record.
Reference Study ID Number: BN44715 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. and Canada) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Barrow Neurological Institute | Phoenix, Arizona, United States | Recruiting |
| Neurology Center of North Orange County | Fullerton, California, United States | Recruiting |
| UC San Diego | La Jolla, California, United States | Recruiting |
| Keck School of Medicine of USC | Los Angeles, California, United States | Recruiting |
| UCLA Neurology Outpatient Clinic | Los Angeles, California, United States | Recruiting |
| Parkinson?s Research Centers of America ? Palo Alto | Palo Alto, California, United States | Recruiting |
| Profound Research LLC at The Neurology Center of Southern California | Pasadena, California, United States | Recruiting |
| UCSF Weill Institute for Neurosciences | San Francisco, California, United States | Recruiting |
| Rocky Mountain Movement Disorders | Englewood, Colorado, United States | Recruiting |
| Institute for Neurodegenerative Disorders | New Haven, Connecticut, United States | Recruiting |
| Georgetown University | Washington D.C., District of Columbia, United States | Recruiting |
+ 162 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07174310